HK:1877 Stock Latest News
Company AnnouncementsJunshi Biosciences Tightens Cash Management of Idle Fundraising Proceeds3d ago
Company AnnouncementsJunshi Biosciences Publishes PRC-Standard Q3 2026 Financials for Cross-Market Investors3d ago- Company AnnouncementsJunshi Biosciences Plans Online Briefing on Q3 2026 Results3d ago
Company AnnouncementsJunshi Biosciences Starts Phase III Trial of JS207–JS007 Combo for Advanced Liver Cancer3d ago
Company AnnouncementsJunshi Wins Full China Approval for Toripalimab in Advanced Urothelial Cancer4d ago
Company AnnouncementsJunshi Biosciences’ Subcutaneous Toripalimab Application Accepted for HER2-Positive Urothelial Cancer4d agoCompany AnnouncementsJunshi Biosciences Starts Phase III Trial of Bispecific Antibody JS203 in Aggressive Lymphoma1w ago
Company AnnouncementsJunshi Biosciences Sets Board Meeting to Approve Nine-Month Unaudited Results2w ago
Company AnnouncementsJunshi Biosciences Grants Reserved A Share Options Under 2025 Incentive Scheme1M ago
Company AnnouncementsShanghai Junshi Biosciences Board Confirms Option Plan Milestone and Cancels Some Options1M ago
Company AnnouncementsShanghai Junshi Biosciences Sets Date for 2026 Interim Results Investor Briefing1M ago- Company AnnouncementsJunshi Biosciences Discloses Planned Stake Reduction by Key A-Share Investor2M ago
Company AnnouncementsJunshi Biosciences Board Approves 2026 Interim Report at Fully Attended Meeting2M agoCompany AnnouncementsShanghai Junshi Biosciences Boosts Revenue, Returns to Profit on TUOYI Growth and Strong Financing2M ago
- Company AnnouncementsShanghai Junshi Biosciences Completes RMB0.7 Billion Technology Innovation Bond Issuance2M ago
Company AnnouncementsJunshi Biosciences Details Stake Reduction by Key Pre-IPO Shareholder2M ago
Company AnnouncementsJunshi Biosciences Sets August Board Meeting to Approve Interim 2026 Results2M ago- Company AnnouncementsJunshi Biosciences Discloses Reduction in Major Shareholder’s Equity Stake2M ago
Company AnnouncementsShanghai Junshi Biosciences Reports Completion of Shareholder’s Stake Reduction2M ago
Company AnnouncementsJunshi Biosciences Completes RMB300 Million Technology Innovation Bond Issuance3M ago